Baker Norton Pharmaceuticals Report issue

For profit Phase 2 Phase 4
Founded: Miami FL United States (2001)
Status: Acquired by Ivax (1989) → now Teva (2006)

Organization Overview

First Clinical Trial
2001
NCT00002189
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

BAKER NORTON | Kunming Baker Norton Pharmaceutical Sales Co., Ltd.

Active Ingredients

Marketed Drugs (1)

urea (1981)

Drugs in Phase 4 Trials (2)

diclofenac (voltaren) (1 trial)

hyaluronic acid (1 trial)

Drugs in Phase 2 Trials (1)

paclitaxel (taxol) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Osteoarthritis (Phase 4)

Osteoarthritis, Knee (Phase 4)

Sarcoma (Phase 2)

Sarcoma, Kaposi (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 3